Esketamine for depression in breast cancer surgery patients
Treatments studied
Part of Cancer, Mental health, Skin clinical trials.
This trial tests whether esketamine, an anesthetic, can help reduce severe depression symptoms in women having breast cancer surgery. You may qualify if you have severe depression before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman 18 or older
- You are scheduled for breast cancer surgery
- You have severe depression symptoms (score of 15 or higher on a depression scale)
- You do not have serious heart, lung, liver, kidney, or bleeding problems
- You are not currently taking antidepressants, antipsychotics, or steroids
- You can understand and fill out the study questionnaires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medication called esketamine during breast cancer surgery can help reduce negative emotions like depression and anxiety after surgery. It is for women who already have mild to severe depression symptoms.
This trial tests whether a medicine called esketamine (given during anesthesia) can help reduce anxiety, sadness, or other negative emotions that often occur before and after breast cancer surgery. This could help you feel better emotionally during your recovery.
This trial studies whether esketamine given around the time of breast cancer surgery can improve depression and change gut bacteria. It also monitors your sleep/deep anesthesia level (with a simple monitoring number).
This study tests whether a low dose of ketamine nasal spray can help reduce depression and anxiety in people living with advanced cancer. If you have a progressive cancer and are feeling down or anxious, you might benefit from this quick treatment.
This study tests whether adding a low dose of esketamine (a type of anesthesia) to modified electroconvulsive therapy (ECT) helps treat severe depression in teenagers. It aims to see if this combination works better and is safer than ECT alone.
This study compares the effectiveness of esketamine (Spravato) and another similar drug, ketamine, for adults with major depression that has not improved after trying at least two other antidepressants. It aims to find out which treatment works better.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.